Fit for purpose, closed automated cell processing system provides improved cell therapy workflows for research through manufacturing
Much like monoclonal antibody manufacturing in the early 1980’s, cell and gene therapy manufacturing is constantly evolving with improved fit-for-purpose technologies being developed to meet expanding industry need. Despite smaller volumes, cell and gene therapy manufacturing is more complex and labor intense than protein-based biologics. Cell and gene therapy processing requires multiple steps and procedures including cell separation, concentration, washing and others. For a successful cell therapy to be produced, it is important to be able to conduct these activities as simply, safely and efficiently as possible....Continued
